This is a routine insider ownership filing with no trading activity. Monitor for any subsequent Form 4 filings that would indicate actual share transactions by Novo Holdings. The IPO conversion trigger is a key catalyst to watch.
Price Chart
Executive Summary
Novo Holdings A/S filed a Form 3 initial statement of beneficial ownership, disclosing ownership of convertible preferred shares in Avalyn Pharma Inc. (AVLN). The filing indicates Novo Holdings holds convertible preferred stock (Series A, B, C-1, C-2, D) that converts into 935,466 + 103,232 + 1,345,997 + 290,390 + 652,649 = 3,327,734 shares of voting common stock on a 1-for-19.2417 basis, with automatic conversion upon IPO. This is a routine insider ownership disclosure with no immediate trading implications.
Key Facts
- Novo Holdings A/S filed Form 3 as an initial beneficial ownership report for Avalyn Pharma Inc.
- Novo Holdings holds convertible preferred stock: Series A (935,466 common), Series B (103,232 common), Series C-1 (1,345,997 common), Series C-2 (290,390 common), Series D (652,649 common).
- Total common shares upon conversion: 3,327,734 shares.
- Conversion ratio is 1 preferred share to 19.2417 common shares, with automatic conversion upon IPO.
- Filing date: April 29, 2026.
Financial Impact
No financial figures disclosed beyond share counts. No dollar amounts reported.
Risk Factors
- No immediate market risk from this filing; it is purely informational.
- Future insider selling by Novo Holdings post-IPO could pressure the stock.
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001388325-26-000017 |
| Document: 0001388325-26-000017-index.html | 0001388325-26-000017 |
| Document: 0001388325-26-000017.txt | 0001388325-26-000017 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 21, 2026 5w ago | Press Release | $31.62 $28.32 | ▼ −10.44% | ▼ −9.42% | $27.14 (−14.17%) |
Aug 16, 2026 10w ago | Institutional Cluster | $38.25 $37.69 | ▼ −1.46% | ▼ −0.27% | $27.14 (−29.05%) |
Aug 12, 2026 10w ago | 8-K | $37.38 $38.97 | ▲ +4.25% | ▲ +4.70% | $27.14 (−27.39%) |
Aug 12, 2026 10w ago | Press Release | $37.38 $38.97 | ▲ +4.25% | ▲ +4.70% | $27.14 (−27.39%) |
Jun 17, 2026 18w ago | 8-K | $29.31 $30.09 | ▲ +2.66% | ▲ +3.70% | $27.14 (−7.40%) |
Jun 17, 2026 18w ago | Press Release | $29.31 $30.09 | ▲ +2.66% | ▲ +3.70% | $27.14 (−7.40%) |
Jun 3, 2026 20w ago | 8-K | $26.40 $28.53 | ▲ +8.07% | ▲ +11.89% | $27.14 (+2.80%) |
May 5, 2026 24w ago | Press Release | $27.71 $29.90 | ▲ +7.90% | ▲ +6.77% | $27.14 (−2.06%) |
May 1, 2026 25w ago | Insider Cluster | $29.07 $29.57 | ▲ +1.72% | ▼ −1.25% | $27.14 (−6.64%) |
May 1, 2026 25w ago | Insider Cluster | $29.07 $29.57 | ▲ +1.72% | ▼ −1.25% | $27.14 (−6.64%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers